04974481 · Active · incorporated 22 years, 8 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops first-in-class cancer therapies, including antibody-drug conjugates and T-cell engagers, through biotechnology research.
https://www.oxfordbiotherapeutics.com
See the complete cap table with every shareholder, founder tags, dilution across 43 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.